Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · Real-Time Price · USD
2.050
+0.020 (0.99%)
Nov 21, 2024, 11:51 AM EST - Market open

Stereotaxis Market Cap

Stereotaxis has a market cap or net worth of $173.70 million as of November 21, 2024. Its market cap has increased by 23.45% in one year.

Market Cap
173.70M
Enterprise Value
172.88M
1-Year Change
23.45%
Ranking
Category
Stock Price
$2.05

Market Cap Chart

Since August 12, 2004, Stereotaxis's market cap has decreased from $183.10M to $173.70M, a decrease of -5.14%. That is a compound annual growth rate of -0.26%.

History

DateMarket Cap% Change
Nov 20, 2024172.00M21.55%
Dec 29, 2023141.50M-8.65%
Dec 30, 2022154.90M-66.50%
Dec 31, 2021462.40M23.27%
Dec 31, 2020375.10M6.26%
Dec 31, 2019353.00M474.92%
Dec 31, 201861.40M237.36%
Dec 29, 201718.20M28.17%
Dec 30, 201614.20M-10.69%
Dec 31, 201515.90M-47.52%
Dec 31, 201430.30M-47.49%
Dec 31, 201357.70M215.30%
Dec 31, 201218.30M-55.90%
Dec 30, 201141.50M-76.45%
Dec 31, 2010176.20M-2.22%
Dec 31, 2009180.20M19.97%
Dec 31, 2008150.20M-63.64%
Dec 31, 2007413.10M27.11%
Dec 29, 2006325.00M49.56%
Dec 30, 2005217.30M991.96%
Dec 31, 200419.90M-89.13%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
2seventy bio 172.31M
DiaMedica Therapeutics 171.07M
Greenwich LifeSciences 169.17M
MediWound 168.76M
Galectin Therapeutics 168.20M
Gossamer Bio 167.36M
Lineage Cell Therapeutics 166.93M
scPharmaceuticals 166.13M
Market Cap Rankings